Description
Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are also contained in pharmaceutical preparations after reasonable safety assessment.
View Full Report At: http://www.marketresearchreports.biz/analysis/232334
China has launched more than 500 types of pharmaceutical excipients, far less than 1,500 types of the United States and 3,000 types of Europe. By market size, gelatin capsules, sucrose, starch, film-coated powder, 1,2-propylene glycol, polyvinylpyrrolidone (PVP), hydroxypropyl methyl cellulose (HPMC), microcrystalline cellulose, hydroxypropyl cellulose (HPC) and lactose rank as the top 10 pharmaceutical excipients in China.
Among them, the traditional pharmaceutical excipients --gelatin capsules are involved with adequate supply and large export volume. In H1 2014, China’s gelatin capsule export volume amounted to 1,427.5 tons and the export value hit USD32.408 million. However, China still relies on the import of film-coated powder, polyvinylpyrrolidone (PVP) and other new-type high-end pharmaceutical excipients.
Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/232334
Currently, pharmaceutical excipients account for about 2%-3% of China's total output value of pharmaceutical preparations. Chinese pharmaceutical excipient market size reached about RMB26.35 billion in 2013 and is expected to be RMB54.83 billion in 2017.
There are about 400 pharmaceutical excipient manufacturers in China, of which over 90 ones or 23% specialize in the production of pharmaceutical excipients, while most of the remaining ones focus on chemical or food processing.
Currently, foreign leading pharmaceutical excipient companies, such as Colorcon (the USA), Degussa (Germany), Meggle (Germany) and Roquette (France), have set up joint ventures, wholly-owned companies or offices in China. Colorcon mainly provides film-coated products; Meggle pharmaceutical lactose, and Roquette pharmaceutical starch and polyols.
Chinese pharmaceutical excipient giants include Er-Kang Pharmaceutical, Sunhere Pharmaceutical Excipients, Dongbao Bio-Tech, Qinghai Gelatin, Shandong Liaocheng A Hua Pharmaceutical, Zhanwang Pharmaceutical and Qufu Tianli, but their market concentration rate is rather low. As a tycoon, Er-Kang Pharmaceutical only seized about 2.7% market share in 2013.
Ranking among the largest Chinese pharmaceutical excipient producers with the most complete types, Er-Kang Pharmaceutical holds 116 types of pharmaceutical excipients and the capacity of 45,000 tons or more. Over the past two years, the company has continued to enforce epitaxial expansion strategy and accelerate market layout. In March 2014, the company acquired 100% stake in Changsha Zhengyang Pharmaceutical Capsule and 51% stake in Hunan Dongting Citric Acid Chemicals. In addition, the company’s 180,000 tons/a medicinal cassava starch production project went into operation on March 31, 2014; the first phase of "South China Pharmaceutical Excipient Base Construction Project" has been completed and will realize production goal at the end of 2014.
Table of Content
1 Overview of Pharmaceutical Excipients
1.1 Overview
1.2 Classification
2 Operating Environment of China Pharmaceutical Excipient Industry
2.1 Economy
2.2 Policies
2.3 Entry Barriers
2.3.1 Qualification
2.3.2 R & D and Technology
2.3.3 Marketing Channels and Brands
2.3.4 Funds
2.4 Upstream and Downstream Environment
2.4.1 Upstream
2.4.2 Downstream
Related Reports
China Recombinant Protein Drug Industry Report, 2014-2017
View Full Report At: http://www.marketresearchreports.biz/analysis/232274
The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%.
Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/232274
The start of recombinant protein drugs in China is not late and common drugs are diversified in variety, for example, recombinant human erythropoietin (rhEPO), recombinant human granulocyte colony-stimulating factor (rhG-CSF).
China Independent Clinical Laboratory Industry Report, 2014-2017
View Full Report At: http://www.marketresearchreports.biz/analysis/226611
The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there was around RMB3.5 billion.
Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/226611
As an industry leader in the business model of "service + agent", DIAN Diagnostics gets involved in independent clinical laboratory, judicial expertise, diagnostic products agency and other areas.
Browse Our Press Releases by Prnewswire: http://www.prnewswire.com/news/marketresearchreports.biz
About Us
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
With a team of experienced consultants we are committed to serve our clients in a way which increase their efficiency, reduce costs and saves time. Our professional search engine helps you in finding the best and latest market research report with just one click of the mouse. Our database represents the most updates and latest market research report collections form all the leading market research publishers across the globe.
Key Points of Marketresearchreports.biz Process
Refining research query
Providing samples and summaries
Quick response time
Helping in making final purchase
Marketresearchreports.biz provides with latest market data and information covering various geographies, industries and companies. We offer special discounts and annual subscriptions to Governments, Embassies, Investment agencies, National statistics agencies, Trade unions, Leading
newspapers and Private publishers.
To get in touch with our Research Coordinators, call us on 866-997-4948 (Us-Canada Toll Free) or drop us an email at: sales@marketresearchreports.biz . We will get back in touch with you within 24 hours.
Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are also contained in pharmaceutical preparations after reasonable safety assessment.
View Full Report At: http://www.marketresearchreports.biz/analysis/232334
China has launched more than 500 types of pharmaceutical excipients, far less than 1,500 types of the United States and 3,000 types of Europe. By market size, gelatin capsules, sucrose, starch, film-coated powder, 1,2-propylene glycol, polyvinylpyrrolidone (PVP), hydroxypropyl methyl cellulose (HPMC), microcrystalline cellulose, hydroxypropyl cellulose (HPC) and lactose rank as the top 10 pharmaceutical excipients in China.
Among them, the traditional pharmaceutical excipients --gelatin capsules are involved with adequate supply and large export volume. In H1 2014, China’s gelatin capsule export volume amounted to 1,427.5 tons and the export value hit USD32.408 million. However, China still relies on the import of film-coated powder, polyvinylpyrrolidone (PVP) and other new-type high-end pharmaceutical excipients.
Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/232334
Currently, pharmaceutical excipients account for about 2%-3% of China's total output value of pharmaceutical preparations. Chinese pharmaceutical excipient market size reached about RMB26.35 billion in 2013 and is expected to be RMB54.83 billion in 2017.
There are about 400 pharmaceutical excipient manufacturers in China, of which over 90 ones or 23% specialize in the production of pharmaceutical excipients, while most of the remaining ones focus on chemical or food processing.
Currently, foreign leading pharmaceutical excipient companies, such as Colorcon (the USA), Degussa (Germany), Meggle (Germany) and Roquette (France), have set up joint ventures, wholly-owned companies or offices in China. Colorcon mainly provides film-coated products; Meggle pharmaceutical lactose, and Roquette pharmaceutical starch and polyols.
Chinese pharmaceutical excipient giants include Er-Kang Pharmaceutical, Sunhere Pharmaceutical Excipients, Dongbao Bio-Tech, Qinghai Gelatin, Shandong Liaocheng A Hua Pharmaceutical, Zhanwang Pharmaceutical and Qufu Tianli, but their market concentration rate is rather low. As a tycoon, Er-Kang Pharmaceutical only seized about 2.7% market share in 2013.
Ranking among the largest Chinese pharmaceutical excipient producers with the most complete types, Er-Kang Pharmaceutical holds 116 types of pharmaceutical excipients and the capacity of 45,000 tons or more. Over the past two years, the company has continued to enforce epitaxial expansion strategy and accelerate market layout. In March 2014, the company acquired 100% stake in Changsha Zhengyang Pharmaceutical Capsule and 51% stake in Hunan Dongting Citric Acid Chemicals. In addition, the company’s 180,000 tons/a medicinal cassava starch production project went into operation on March 31, 2014; the first phase of "South China Pharmaceutical Excipient Base Construction Project" has been completed and will realize production goal at the end of 2014.
Table of Content
1 Overview of Pharmaceutical Excipients
1.1 Overview
1.2 Classification
2 Operating Environment of China Pharmaceutical Excipient Industry
2.1 Economy
2.2 Policies
2.3 Entry Barriers
2.3.1 Qualification
2.3.2 R & D and Technology
2.3.3 Marketing Channels and Brands
2.3.4 Funds
2.4 Upstream and Downstream Environment
2.4.1 Upstream
2.4.2 Downstream
Related Reports
China Recombinant Protein Drug Industry Report, 2014-2017
View Full Report At: http://www.marketresearchreports.biz/analysis/232274
The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%.
Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/232274
The start of recombinant protein drugs in China is not late and common drugs are diversified in variety, for example, recombinant human erythropoietin (rhEPO), recombinant human granulocyte colony-stimulating factor (rhG-CSF).
China Independent Clinical Laboratory Industry Report, 2014-2017
View Full Report At: http://www.marketresearchreports.biz/analysis/226611
The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there was around RMB3.5 billion.
Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/226611
As an industry leader in the business model of "service + agent", DIAN Diagnostics gets involved in independent clinical laboratory, judicial expertise, diagnostic products agency and other areas.
Browse Our Press Releases by Prnewswire: http://www.prnewswire.com/news/marketresearchreports.biz
About Us
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
With a team of experienced consultants we are committed to serve our clients in a way which increase their efficiency, reduce costs and saves time. Our professional search engine helps you in finding the best and latest market research report with just one click of the mouse. Our database represents the most updates and latest market research report collections form all the leading market research publishers across the globe.
Key Points of Marketresearchreports.biz Process
Refining research query
Providing samples and summaries
Quick response time
Helping in making final purchase
Marketresearchreports.biz provides with latest market data and information covering various geographies, industries and companies. We offer special discounts and annual subscriptions to Governments, Embassies, Investment agencies, National statistics agencies, Trade unions, Leading
newspapers and Private publishers.
To get in touch with our Research Coordinators, call us on 866-997-4948 (Us-Canada Toll Free) or drop us an email at: sales@marketresearchreports.biz . We will get back in touch with you within 24 hours.
0 comments:
Post a Comment